Prosthetic Knees for Above-Knee Amputation
Trial Summary
What is the purpose of this trial?
The goal of this proposed project is to gather community-based data from the K2-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators intend to use this trial data along with a concurrent study being conducted within the K3-K4 level population to guide the implementation of effective prescriptions towards those that can benefit most from a given device and limit prescription to those who would not see benefit in order to ensure the most judicious use of Department of Defense (DoD) and Veteran's Affairs healthcare dollars. The findings will also be shared with the research community to help drive the design of future devices by identifying what features and functions are most beneficial to which patient populations when the devices are used outside of the laboratory. In summary, more community-based data on how powered prosthetic knees compare with the current standard in TFA populations is needed to allow for improved clinical decision making and clinical outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
How does the Ossur Power Knee differ from other prosthetic knee treatments for above-knee amputation?
The Ossur Power Knee is unique because it actively generates power at the knee joint, unlike passive prosthetic knees, which only dissipate energy. This active power generation can improve walking and stair climbing by reducing the strain on the remaining joints and enabling more natural movements.12345
Research Team
Jennifer Johansson, MS
Principal Investigator
Liberating Technologies, Inc.
Eligibility Criteria
This trial is for individuals with above-knee amputations, specifically K2-level transfemoral amputees. It's aimed at those who use prosthetic knees and are looking to improve their mobility. The study excludes certain groups based on specific criteria not provided here.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training and Acclimation
Participants are trained and acclimated to each prosthetic knee condition during the first month of the take-home period
Condition Testing
Participants wear each prosthetic knee at home for three months, with periodic assessments and follow-up calls
Follow-up
Participants are monitored for safety and effectiveness after completing all conditions
Treatment Details
Interventions
- Ossur Power Knee
- Reboocon Intuy Knee
Ossur Power Knee is already approved in United States, European Union for the following indications:
- Transfemoral amputation in K2-level ambulators
- Transfemoral amputation in K2-level ambulators
Find a Clinic Near You
Who Is Running the Clinical Trial?
Liberating Technologies, Inc.
Lead Sponsor
Hanger Clinic: Prosthetics & Orthotics
Collaborator